Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by FELIQS CORPORATION

FELIQS announces $9 Million Series A Financing to Advance FLQ-101 Clinical Program for Retinopathy of Prematurity
From FELIQS CORPORATION
Via Business Wire
FELIQS Receives U.S. FDA Fast Track Designation for FLQ-101, a First-in-class Small Molecule to Prevent Retinopathy of Prematurity
From FELIQS Corporation
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.